Gene variants and lung cancer risk
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how certain gene variations (called ADH1B and ALDH) may affect the risk of developing lung cancer. By comparing people with lung cancer to healthy individuals, researchers hope to learn more about who might be at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer (confirmed by a biopsy or pathology report), OR you are a healthy adult.
- You are at least 18 years old.
- You can provide the necessary medical or health information for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This study looks for biological markers (biomarkers) in your cancer tissue to help predict whether the tumor might spread through air spaces. It aims to better understand your cancer and may help guide future treatment decisions.
This study looks at people with lung nodules or masses, or those at high risk for lung cancer, to improve how doctors predict cancer risk and recurrence. It combines imaging, blood tests, and tissue samples to better personalize care.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
This study looks at tissue samples from people with lung cancer to learn more about the genes and molecules that cause it. By participating, you may help doctors better understand lung cancer and improve future treatments.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.